Agilent Technologies (NYSE:A) Issues FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.860-6.000 for the period, compared to the consensus estimate of 6.000. The company issued revenue guidance of $7.3 billion-$7.4 billion, compared to the consensus revenue estimate of $7.3 billion. Agilent Technologies also updated its Q1 2026 guidance to 1.350-1.380 EPS.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. TD Cowen increased their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. Evercore ISI lifted their target price on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. JPMorgan Chase & Co. lifted their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research report on Monday, September 15th. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Stock Up 1.3%

Shares of NYSE:A traded up $1.99 during midday trading on Monday, hitting $153.24. 3,907,500 shares of the company’s stock traded hands, compared to its average volume of 1,901,624. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies has a twelve month low of $96.43 and a twelve month high of $153.84. The company has a market cap of $43.44 billion, a PE ratio of 35.97, a P/E/G ratio of 4.67 and a beta of 1.29. The firm’s fifty day moving average price is $139.65 and its two-hundred day moving average price is $125.37.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, meeting analysts’ consensus estimates of $1.59. The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. On average, equities research analysts anticipate that Agilent Technologies will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is presently 23.94%.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the sale, the chief executive officer owned 33,448 shares in the company, valued at $5,017,200. This represents a 27.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.26% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Agilent Technologies

Several hedge funds have recently made changes to their positions in A. Ameriprise Financial Inc. lifted its stake in Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after acquiring an additional 1,340,161 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after buying an additional 1,652,244 shares during the period. Marshall Wace LLP grew its holdings in shares of Agilent Technologies by 5.3% during the 3rd quarter. Marshall Wace LLP now owns 1,591,891 shares of the medical research company’s stock valued at $204,319,000 after acquiring an additional 80,768 shares in the last quarter. Alliancebernstein L.P. increased its stake in shares of Agilent Technologies by 24.0% in the third quarter. Alliancebernstein L.P. now owns 815,353 shares of the medical research company’s stock worth $104,651,000 after acquiring an additional 157,919 shares during the last quarter. Finally, Man Group plc raised its holdings in shares of Agilent Technologies by 59.8% during the second quarter. Man Group plc now owns 729,889 shares of the medical research company’s stock worth $86,134,000 after acquiring an additional 273,253 shares in the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.